Takeda Buy Of Millennium Of U.S. Boosts Drug Discovery For Both
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical's purchase of U.S.-based Millennium Pharmaceuticals for $8.8 billion in 2008 appears to have dispelled initial fears the Boston firm would be subsumed